Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Prostate Cancer Prostate Cancer for November/December 2019 Phase II Trial of DNA Vaccine Encoding PAP in Patients with PCa , Utilization of Surgery for Post-prostatectomy Incontinence, Claims Analysis of Advanced PCa Treatment Costs and Resource Use, Testosterone Therapy Doesn't Increase Prostate Cancer Risk, Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced PCa, More must reads Prostate Cancer for September/October 2019 Total Cost of Care for Castration-Resistant Prostate Cancer, Elevating SOX2 in Prostate Tumor Cells , Chronic Oral Anticoagulation and Risk of Prostate Cancer, Prostate Cancer Detection Rate of Free-Hand vs 3D Template Mapping Biopsy, Association of Statin Use With Risk of Specific Prostate Cancer, More must readsProstate Cancer for July/August 2019 HIV, Cancer Treatment, and Prostate Cancer Outcomes Among Elderly Adults, Low Natural Killer Cell Activity Increases PCa Risk in Veteran Men Undergoing Biopsy, Prostate CE-TRUS Evaluation with Whole Mount Prostatectomy Correlation, Testosterone Accumulation in PCa Cells Enhanced by Facilitated Diffusion, Characterization of GLYATL1 in Prostate Cancer, More must readsProstate Cancer for May/June 2019 Tumor Cell Detection System for Prostate Cancer, Early Biochemical Predictors of Survival in High-Risk Prostate Cancer , Robot-Assisted Radical Prostatectomy, FGF9 as a Biomarker in Prostate Cancer Diagnosis, Urolithin A Induces Prostate Cancer Cell Death, More must readsProstate Cancer for March/April 2019 Self-Management in Long-Term Prostate Cancer, Physical Activity and the Risk of Prostate Cancer, Stereotactic Body Radiotherapy for Prostate Cancer , CVD Risk After Robotic-Assisted Radical Prostatectomy, Proton vs Photon-Based Radiation Therapy for PC, More must reads
